Ikena Oncology Presents Data at AACR-NCI-EORTC Virtual Conference Demonstrating Potential of TEAD Inhibitors in Cancer Treatment

NEXT STORY
Medicenna Presents MDNA11 Data from IND-Enabling Studies at the AACR-NCI-EORTC Conference
PREV STORY
ORIC Pharmaceuticals Presents Initial Clinical Data from Phase 1b Trial of ORIC-101 in Combination with Enzalutamide and Preclinical Data on ORIC-114 at AACR-NCI-EORTC
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Sublimity Therapeutics Receives Investigational New Drug (IND) Clearance from U.S. Food and Drug Administration (FDA)

Company also Receives Ireland Authorization and Health Canada Clearance Phase 2b Clinical Trial of ...

author_avatar
NASDAQ Market News

NeoGenomics Schedules its Second Quarter Earnings Release for July 24, 2018

FT. MYERS, Fla., July 02, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ:NEO), a leading ...

author_avatar
NASDAQ Market News

Cancer Genetics, Inc. to Present at the 7th Annual LD Micro Invitational

LOS ANGELES, June 02, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) (“CGI” or ...

author_avatar
NASDAQ Market News